JUSTICE PUBLIC SAFETY
Judge approves $7 billion Bayer settlement over claims its Roundup weedkiller caused cancer
A Missouri judge approved Bayer’s nationwide settlement to pay up to $7.25 billion over about two decades to resolve most U.S. lawsuits claiming Roundup weedkiller exposure caused non-Hodgkin lymphoma, while Bayer continues to deny the product causes cancer.
A Missouri judge approved Bayer’s nationwide settlement to pay up to $7.25 billion over about two decades to resolve most U.S. lawsuits claiming Roundup weedkiller exposure caused non-Hodgkin lymphoma, while Bayer continues to deny the product causes cancer.
Corroboration
LowMedHigh
Confirmed by 26+ sources.
What This is
- A Missouri state judge gave final approval to Bayer’s nationwide Roundup settlement, calling it fair, reasonable, and adequate.
- The deal covers claims that Roundup’s main ingredient, glyphosate, caused non-Hodgkin lymphoma.
- Bayer will pay up to about $7.25 billion over roughly 20 to 21 years under the settlement.
- Individual awards are generally reported as ranging from about $10,000 to $165,000, depending on factors like exposure and illness severity.
- The settlement is intended to resolve most current U.S. Roundup lawsuits and set up a process for people who may develop the disease in the future.
- Bayer says it does not agree that Roundup causes cancer but pursued the deal to reduce litigation costs and uncertainty.
Why This Matters
- The settlement shows how mass-tort litigation can push companies to pay large sums even while they deny wrongdoing.
- It affects what compensation looks like for people who say a product harmed them, including how much they may receive and how long payments can take.
- Disputes over whether glyphosate causes cancer highlight how hard it can be to settle public health risks when science, regulators, and courts do not align.





